NCT02424786.

Methods	RCT
Participants	Inclusion: patients > 65 years in dialysis treatment or with CKD stage 5
Interventions	Medication lists from patients randomised to the intervention group will be evaluated by the research physician with the help of STOPP/START criteria Feedback on this screening will be given to the team responsible for patient treatment
Outcomes	Medication non‐adherence ‐ measured by Morisky Medication Adherence Scale and visual adherence scale Secondary outcomes: improvement in polypharmacy, associations between beliefs about medication/anxiety/depression with adherence and QoL, predictors of non‐adherence, risk factors for non‐adherence, changes in number of inappropriate medications
Notes	NCT02424786 Start date: May 2015. Study completion: September 2017 Results manuscripts currently being prepared Investigator contacted ‐ Krystina Parker confirmed: 180 patients, mean number of medications 11.1 (range 4 to 19)